| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 08/15/2000 | US6102254 Pharmaceutical compositions in semisolid form and a device for administration thereof |
| 08/15/2000 | CA1341087C Medicaments including hyaluronic acid as a drug delivery system |
| 08/10/2000 | WO2000046390A1 T helper cell epitopes |
| 08/10/2000 | WO2000046221A1 Sulfamato hydroxamic acid metalloprotease inhibitor |
| 08/10/2000 | WO2000045828A1 Soya extract containing lipids, process for its production, and pharmaceutical and cosmetic composition |
| 08/10/2000 | WO2000045819A1 Use of cholesterol-lowering agent |
| 08/10/2000 | WO2000045818A1 Use of 3-hydroxy-3-methylglutaryl coenzym a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy |
| 08/10/2000 | WO2000045817A1 Drug combinations comprising (e) -7 - [4 -(4 -fluorophenyl) -6 - isopropyl -2 - [methyl (methylsulfonyl) amino] pyrimidin -5 -yl] (3r,5s) -3,5 - dihydroxyhept -6 - enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3a4 |
| 08/10/2000 | WO2000045808A1 Preparation for warts |
| 08/10/2000 | WO2000045795A2 Topical sprays comprising a film forming composition |
| 08/10/2000 | WO2000016746A8 Immunogenic liposome compositions |
| 08/10/2000 | DE19904352C1 Lipide enthaltender Soja-Extrakt, Verfahren zu dessen Herstellung und pharmazeutische bzw. kosmetische Zusammensetzung sowie deren Verwendung zur Prävention oder Behandlung von trockener Haut Lipids containing soy extract, process for its preparation and to pharmaceutical or cosmetic composition and the use thereof for the prevention or treatment of dry skin |
| 08/10/2000 | CA2362230A1 Sulfamato hydroxamic acid metalloprotease inhibitor |
| 08/10/2000 | CA2361658A1 T helper cell epitopes |
| 08/10/2000 | CA2358641A1 Use of cholesterol-lowering agent |
| 08/10/2000 | CA2349703A1 Soya extract containing lipids, process for its production, and pharmaceutical and cosmetic composition |
| 08/09/2000 | EP1025838A1 A cosmetic composition and a method for reducing the ageing processes of skin |
| 08/09/2000 | EP1025834A1 Use for direct hair dye a combination of two cationic dyes |
| 08/09/2000 | EP1025125A1 Aggregates of human insulin derivatives |
| 08/09/2000 | EP1024837A1 Ultrasound imaging with contrast agent targeted to microvasculature and a vasodilator drug |
| 08/09/2000 | EP1024805A1 Use of coumarin derivatives for the treatment of digestive tract disorders |
| 08/09/2000 | EP1024786A1 Skin compatible hand cleanser, especially a course hand cleanser |
| 08/09/2000 | CN1262675A (+)-Norcisapride useful for 5-HT3 and 5-HT4 mediated disorbers |
| 08/09/2000 | CN1262615A Mild, rinse-off antimicrobial liquid cleansing compositions containing acidic surfactants |
| 08/08/2000 | US6099827 Comprising antiperspirant or deodorant active material, moisturizing cream, and non-polar hydrocarbon propellant composition |
| 08/03/2000 | WO2000044846A1 Adhesives |
| 08/03/2000 | WO2000044763A2 Compositions for treating inflammatory response |
| 08/03/2000 | WO2000044728A1 Substituted bicyclic derivatives useful as anticancer agents |
| 08/03/2000 | WO2000044716A1 Acetylenic sulfonamide thiol tace inhibitors |
| 08/03/2000 | WO2000037062A3 Phospholipid complexes of proanthocyanidin a2 as antiatherosclerotic agents |
| 08/03/2000 | WO2000023065A3 Storable active substance concentrate with formoterol |
| 08/03/2000 | WO2000015179A3 Cosmetic composition |
| 08/03/2000 | WO1999062561A3 Gene therapy method |
| 08/03/2000 | CA2361614E Compositions for treating inflammatory response |
| 08/03/2000 | CA2360195A1 Adhesives |
| 08/03/2000 | CA2356480A1 Acetylenic sulfonamide thiol tace inhibitors |
| 08/03/2000 | CA2356313A1 Alkynyl containing hydroxamic acid derivatives, their preparation and their use as matrix metalloproteinase (mmp) inhibitors/tnf-alpha converting enzyme (tace) inhibitors |
| 08/02/2000 | EP1024189A1 Novel antigenic class of avian reoviruses |
| 08/02/2000 | EP1023316A2 Methods and compositions for lipidization of hydrophilic molecules |
| 08/02/2000 | EP1023043A2 Cleansing compositions |
| 08/02/2000 | CN1261800A Method of treatment of lever tumours and pharmaceutical compositions for use therein |
| 08/02/2000 | CN1261796A Self-emulsifying formulation for lipophilic compounds |
| 08/02/2000 | CN1261793A Sertraline salts and substained-release dosage forms of sertraline |
| 08/02/2000 | CN1261787A Cosmetic skin conditioning compositions |
| 08/01/2000 | US6096697 Personal cleansing compositions providing improved hair and skin conditioning |
| 08/01/2000 | CA2209925C 5,6-diaryl-5,6,7,8-tetrahydronaphthalenes and their analogs as estrogen agonists/antagonists |
| 08/01/2000 | CA2026036C Sulphated glycosamino glycuronan with antithrombotic activity |
| 08/01/2000 | CA2005714C Transdermal estrogen/progestin dosage unit, system and process |
| 07/27/2000 | WO2000043378A1 New morpholinobenzamide salts |
| 07/27/2000 | WO2000043021A1 Pharmaceutical composition for the treatment of rheumatic syndromes containing sulfur, mustard seeds and a copper salt |
| 07/27/2000 | WO2000042992A2 Compositions and methods for mucosal delivery |
| 07/27/2000 | WO2000042981A1 Dual component dentinal desensitizing dentifrice |
| 07/27/2000 | WO2000025724A3 COMPOSITIONS COMPRISING OLEUM $i(MELALEUCA) |
| 07/27/2000 | WO2000023433A8 Substituted benzopyran analogs for the treatment of inflammation |
| 07/27/2000 | CA2359482A1 Organoprotective solutions |
| 07/27/2000 | CA2359105A1 New morpholinobenzamide salts |
| 07/27/2000 | CA2358524A1 Compositions and methods for mucosal delivery |
| 07/27/2000 | CA2358474A1 Pharmaceutical composition for the treatment of rheumatic syndromes containing sulfur, mustard seeds and a copper salt |
| 07/26/2000 | EP1021410A1 Prostaglandin agonists and their use to treat bone disorders |
| 07/26/2000 | EP1021204A2 Bioadhesive compositions and methods for topical administration of active agents |
| 07/26/2000 | EP1021194A1 New improved formulation for treatment of osteoporosis |
| 07/26/2000 | EP1021162A2 Cosmetic compositions containing azelaic acid |
| 07/26/2000 | CN1261365A Crystalline macrolides and process for their preparation |
| 07/26/2000 | CN1261362A Omeprazole sodium salt |
| 07/26/2000 | CN1261354A Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p561ck tyrosine kinases |
| 07/26/2000 | CN1261353A Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p561ck tyrosine kinases |
| 07/26/2000 | CN1261279A Pharmaceutical compositions containing eletriptan hemisulphate and caffeine |
| 07/25/2000 | US6093724 Muscarinic agonists and antagonists |
| 07/25/2000 | CA2190959C Combined two-part reducing agent/humectant shaving system for improved shaving comfort |
| 07/20/2000 | WO2000042044A1 Novel aralkyl amines of spirofuropyridines useful in therapy |
| 07/20/2000 | WO2000042040A1 Tricyclic inhibitors of poly(adp-ribose) polymerases |
| 07/20/2000 | WO2000042031A2 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents |
| 07/20/2000 | WO2000041708A1 Composition for treating obesity and aesthetic treatment method |
| 07/20/2000 | WO2000041548A2 Methods for glucagon suppression |
| 07/20/2000 | WO2000041546A2 Novel exendin agonist formulations and methods of administration thereof |
| 07/20/2000 | WO2000041545A2 Regulators of the pct or smoothened pathway, compositions and uses related thereto |
| 07/20/2000 | WO2000016732A3 ANTI-MICROBIAL-ADHESION FRACTION DERIVED FROM $i(VACCINIUM) |
| 07/20/2000 | CA2370042A1 Regulators of the pct or smoothened pathway, compositions and uses related thereto |
| 07/20/2000 | CA2359990A1 Novel aralkyl amines of spirofuropyridines useful in therapy |
| 07/20/2000 | CA2359562A1 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents |
| 07/20/2000 | CA2356706A1 Novel exendin agonist formulations and methods of administration thereof |
| 07/20/2000 | CA2323711A1 Composition for treating obesity and aesthetic treatment method |
| 07/19/2000 | EP1020461A2 Use of alkaline salts of the (-)-enantiomer of omeprazole |
| 07/19/2000 | EP1020460A2 The sodium salt of the (-)-enantiomer of omeprazole |
| 07/19/2000 | EP1019089A2 Long-acting drugs and pharmaceutical compositions comprising them |
| 07/19/2000 | EP1019050A1 Use of somatostatin agonists and antagonists for treating diseases related to the eye |
| 07/19/2000 | EP1019049A1 Methods and compositions for treating and/or preventing non-insulin dependent diabetes mellitus (niddm) using specific retinoid compounds |
| 07/19/2000 | CN1260717A Use of 1-ar (alk)yl-imidazoline-2-one for treating anxietyand stress conditions |
| 07/19/2000 | CN1054603C Tri-substituted phenyl derivatives and medicinal composition containing same |
| 07/19/2000 | CN1054599C Hydroxamic acid derivatives and preparation method and use |
| 07/19/2000 | CN1054507C Preparation method for medicinal composition for treatment of vaginal infections |
| 07/19/2000 | CN1054504C Tooth-cleaning unit |
| 07/18/2000 | CA2014633C Stable anhydrous compositions for topical delivery of active materials |
| 07/13/2000 | WO2000040257A1 Method for producing an antitumoral agent and antitumoral agent thus obtained |
| 07/13/2000 | WO2000020073A3 Reactive nanoparticles as destructive adsorbents for biological and chemical contamination |
| 07/12/2000 | EP1017362A1 Fluoride dentifrices of enhanced efficacy |
| 07/12/2000 | EP1017360A1 Nonaerosol shave gel compositions |
| 07/12/2000 | CN1259999A Human bikunin |
| 07/12/2000 | CN1259861A Desensitizing dentifrice having limited astringency |
| 07/12/2000 | CN1259346A Optically pure compound as medicinal use |